W Notcutt

Summary

Affiliation: Great Yarmouth
Country: UK

Publications

  1. doi request reprint A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine
    William G Notcutt
    Pain Research Unit, James Paget University Hospital, Great Yarmouth, Norfolk, UK
    Prim Health Care Res Dev 14:192-9. 2013
  2. doi request reprint A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
    W Notcutt
    James Paget University Hospital, Pain Management Department, Gorleston on Sea, UK
    Mult Scler 18:219-28. 2012

Detail Information

Publications2

  1. doi request reprint A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine
    William G Notcutt
    Pain Research Unit, James Paget University Hospital, Great Yarmouth, Norfolk, UK
    Prim Health Care Res Dev 14:192-9. 2013
    ..To identify the areas of daily function most affected by the introduction of Sativex, a cannabis-based medicine, and the impact on caregivers and people with multiple sclerosis (MS)...
  2. doi request reprint A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
    W Notcutt
    James Paget University Hospital, Pain Management Department, Gorleston on Sea, UK
    Mult Scler 18:219-28. 2012
    ..Open-label studies are not ideal for providing robust evidence for long-term maintenance of efficacy of medicines, especially where medicines provide symptom relief and where long-term use of a placebo may be problematic and not ethical...